Answers are grounded in this paper and cite their sources.
Evaluates Kco's relationship with emphysema progression and lung function decline in heavy smokers, suggesting its importance as a biomarker.
Background: The transfer coefficient Kco is a measurement of the ability of the lungs to transfer gas from air to the pulmonary capillaries. A decrease in Kco is associated with emphysema. Aim: To evaluate whether the Kco was associated with the progression of CT-detected emphysema and decline of lung function. Methods: 522 heavy smokers, mean (SD) 41.3 (18.7) pack years, participating in a lung cancer screening trial underwent diffusion testing and CT-scanning of the lungs. CT-scanning was repeated after median (interquartile range) 2.8 (2.7-3.0) years and emphysema was assessed by lung densitometry using the 15th percentile (Perc15, point below which 15% of the low attenuation areas voxels are distributed). The association between Kco at baseline with progression of emphysema and lung function decline was assessed by multiple linear regression, correcting for baseline CT-quantified emphysema severity and FEV 1 /FVC, age, height, BMI, pack years and smoking status. Results: Mean (SD) age was 60.1 (5.4) years, Perc15 was -938 (19), FEV 1 /FVC was 71.6% (9) and Kco was 1.23 (0.25), which is 81.8% (16.5) of predicted. A lower baseline Kco was significantly related to an increased progression of CT-quantified emphysema and a more rapid decline in FEV 1 /FVC. A one standard deviation (0.25) lower Kco value at baseline, predicted a 1.6 HU lower Perc15 and a 0.78% lower FEV 1 /FVC after follow-up (p<0.001). Conclusion: A lower baseline Kco value is independently associated with a more rapid progression of emphysema and lung function decline in heavy smokers.
No takes yet. Share an insight, caveat, or question.
Hoesein et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: